Lymphoproliferative disease: prevention and management

E.M.A. Verschuuren (Groningen, The Netherlands)

Source: School Course 2012 - Lung Transplantation
Number: 37

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E.M.A. Verschuuren (Groningen, The Netherlands). Lymphoproliferative disease: prevention and management. School Course 2012 - Lung Transplantation

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Immunodeficiencies in adulthood: lung disease manifestations and treatment options
Source: International Congress 2019 – PG6 Immunodeficiencies in lung diseases
Year: 2019


Multidisciplinary approach to systemic diseases: benefits for diagnosis and management of complex disorders
Source: Eur Respir Monogr 2019; 86: 1-13
Year: 2019


Pulmonary embolism in China: disease burden, management and prevention
Source: Virtual Congress 2020 – Chinese programme 2020: Part II
Year: 2020


Lymphoproliferative disease and other malignancies
Source: ERS Course 2016
Year: 2016



Strategy for early diagnosis and intervention in chronic respiratory disease
Source: Virtual Congress 2020 – Chinese programme 2020: Part I
Year: 2020

Sarcoidosis: pulmonary manifestations and management
Source: Eur Respir Monogr 2019; 86: 404-418
Year: 2019


Scleroderma lung disease: Risk factors and treatment options
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010

Prioritised research agenda for prevention and control of chronic respiratory diseases
Source: Eur Respir J 2010; 36: 995-1001
Year: 2010



Multidisciplinary management for peadiatric chronic respiratory disease
Source: Annual Congress 2004 - Psychosocial and behavioural aspects of chronic respiratory diseases
Year: 2004

Rare lung diseases in children: challenges for diagnosis and treatment
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021


Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013

Risk factors and treatment outcomes in patients with chronic pulmonary aspergillosis
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Pre-transplant management of co-existing diseases
Source: Eur Respir Mon; 2009: 45: 54–61
Year: 2009

Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

Managing tuberculosis in chronic kidney disease: An evaluation of patient treatment regimens
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011



Pulmonary manifestations in patients with IgG4-related disease at a tertiary care institute
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015


Costs and effectiveness of a disease management program for chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012